Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-12,730
Closed -$536K 954
2021
Q3
$536K Sell
12,730
-505
-4% -$25K 0.13% 176
2021
Q2
$649K Buy
13,235
+9,894
+296% +$467K 0.15% 139
2021
Q1
$139K Buy
+3,341
New +$126K 0.04% 348
2018
Q4
Sell
-1
Closed -$28 733
2018
Q3
$28 Hold
1
﹤0.01% 665
2018
Q2
$30 Hold
1
﹤0.01% 654
2018
Q1
$38 Hold
1
﹤0.01% 579
2017
Q4
$38 Sell
1
-6,071
-100% -$197K ﹤0.01% 577
2017
Q3
$152K Buy
6,072
+2,062
+51% +$56.3K 0.03% 216
2017
Q2
$118K Buy
+4,010
New +$104K 0.03% 258

Other funds holding SKX

Exane Derivatives's SKX Position: Q4 2021 in Review

Exane Derivatives sold out of Skechers (SKX) in Q4 2021, closing a stake of 12,730 shares — an estimated $536K sold.

Exane Derivatives first reported a position in SKX in Q2 2017 and held it in 9 quarters. The position peaked at $649K in Q2 2021. 312 funds tracked by Wall St. Rank hold SKX as of Q4 2021.

  • Exane Derivatives reported no remaining Skechers position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 12,730 Skechers shares in Q4 2021, an estimated $536K.
  • Exane Derivatives first reported a position in Skechers in Q2 2017 and held it in 9 quarters.
  • Exane Derivatives's Skechers position peaked at $649K in Q2 2021.
  • 312 funds tracked by Wall St. Rank held Skechers as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.